tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tango Therapeutics’ Promising Update on TNG260 Clinical Study
PremiumCompany AnnouncementsTango Therapeutics’ Promising Update on TNG260 Clinical Study
20d ago
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors
Premium
Company Announcements
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors
20d ago
Tango Therapeutics price target raised to $12 from $10 at Guggenheim
Premium
The Fly
Tango Therapeutics price target raised to $12 from $10 at Guggenheim
23d ago
Tango Therapeutics prices 21M shares at $8.66 in underwritten offering
PremiumThe FlyTango Therapeutics prices 21M shares at $8.66 in underwritten offering
24d ago
Tango Therapeutics announces positive data from Phase 1/2 study of vopimetostat
Premium
The Fly
Tango Therapeutics announces positive data from Phase 1/2 study of vopimetostat
24d ago
Tango Therapeutics granted orphan designation for treatment of malignant glioma
Premium
The Fly
Tango Therapeutics granted orphan designation for treatment of malignant glioma
1M ago
Tango Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe FlyTango Therapeutics initiated with an Overweight at Piper Sandler
3M ago
Tango Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Tango Therapeutics Reports Q2 2025 Financial Results
3M ago
Tango Therapeutics reports Q2 EPS (35c), consensus (34c)
Premium
The Fly
Tango Therapeutics reports Q2 EPS (35c), consensus (34c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100